Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sedana Medical ABOSTO:SEDANA -1.01%69 PB Ratio is 1.10 as of Aug. 02, 2026, which is 76% below its 10-year median of 4.68. GuruFocus rates OSTO:SEDANA with a GF Score™ of 69/100 and a GF Value™ of kr17.42 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Sedana Medical AB ranks better than 76.9% on this metric.
Sedana Medical AB stock PB Ratio (=0.98) is close to 1-year low of 0.9.
The historical rank and industry rank for Sedana Medical AB's PB Ratio or its related term are showing as below:
OSTO:SEDANA'
s PB Ratio Range Over the Past 10 Years
Min: 0.81 Med: 4.68 Max: 534.09
Current: 1.09
During the past 11 years, Sedana Medical AB's highest PB Ratio was 534.09. The lowest was 0.81. And the median was 4.68.
OSTO:SEDANA's PB Ratio is ranked better than 76.9% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs OSTO:SEDANA: 1.09
During the past 12 months, Sedana Medical AB's average Book Value Per Share Growth Rate was -3.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -4.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 4.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 87.90% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Sedana Medical AB was 640.60% per year. The lowest was -4.50% per year. And the median was 35.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sedana Medical AB PB Ratio Related Terms
Sedana Medical AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Sedana Medical AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sedana Medical AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sedana Medical AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sedana Medical AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sedana Medical AB (OSTO:SEDANA) has a PB Ratio of 1.10 as of Aug. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sedana Medical AB and its competitors. This is 76% below median its historical median of 4.68. Over the past decade, Sedana Medical AB's PB Ratio has ranged from 0.81 to 534.09. According to the industry distribution chart, Sedana Medical AB ranks #182 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 23.1%.
Is Sedana Medical AB's PB Ratio too high?
Sedana Medical AB's current PB Ratio of 1.10 is 76% below median its 10-year median of 4.68. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 534.09. The Medical Devices & Instruments industry median PB Ratio is 2.06. Sedana Medical AB's value of 1.10 is 46.6% below this industry median. Based on the distribution chart, Sedana Medical AB ranks #182 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sedana Medical AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sedana Medical AB ranks #182 out of 788 companies for PB Ratio. This places Sedana Medical AB in the top 23% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.06. Sedana Medical AB's value of 1.10 is 46.6% below this benchmark. Historically, Sedana Medical AB's own PB Ratio has ranged from 0.81 to 534.09 over the past decade. While the company's 10-year median is 4.68 vs. the industry median of 2.06, Sedana Medical AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.06, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sedana Medical AB's current PB Ratio of 1.10 is 46.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sedana Medical AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sedana Medical AB's current PB Ratio is 1.10, which is 76% below median its own 10-year median of 4.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Sedana Medical AB (OSTO:SEDANA) is currently considered Significantly Undervalued. The stock's GF Value™ is kr17.42, compared to a current price of kr9.80 — trading 43.7% below its estimated fair value. The current PB Ratio is 1.10, which is 76% below median its 10-year median of 4.68 and 46.6% below the Medical Devices & Instruments industry median of 2.06. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sedana Medical AB (OSTO:SEDANA), the current PB Ratio is 1.10 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sedana Medical AB (OSTO:SEDANA) Overvalued in 2026?
Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued.
The current stock price of kr9.80 is trading 43.7% below its estimated GF Value™ of kr17.42.
GuruFocus considers Sedana Medical AB to be Significantly Undervalued.
Key valuation signals for OSTO:SEDANA:
PB Ratio: 1.10 (76% below median its 10-year median of 4.68)
GF Value™: kr17.42 vs. price of kr9.80 (43.7% below fair value)
Industry Position: 46.6% below the Medical Devices & Instruments median (#182 of 788)
No single metric tells the full story. See the OSTO:SEDANA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score
Get the complete analysis for OSTO:SEDANA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SEDANA has been successfully added to your 
